1. Allenby, G; Bocquel, MT; Saunders, M; Kazmer, S; Speck, J; Rosenberger, M; Lovey, A; Kastner, P; Grippo, JF; Chambon, P. (1993) Retinoic acid receptors and retinoid X receptors: interactions with endogenous retinoic acids.
Proc. Natl. Acad. Sci. U.S.A., 90 (1): 30-4.
[PMID:8380496]
2. Almasan, A; Mangelsdorf, DJ; Ong, ES; Wahl, GM; Evans, RM. (1994) Chromosomal localization of the human retinoid X receptors.
Genomics, 20 (3): 397-403.
[PMID:8034312]
3. Belanger, AJ; Luo, Z; Vincent, KA; Akita, GY; Cheng, SH; Gregory, RJ; Jiang, C. (2007) Hypoxia-inducible factor 1 mediates hypoxia-induced cardiomyocyte lipid accumulation by reducing the DNA binding activity of peroxisome proliferator-activated receptor alpha/retinoid X receptor.
Biochem. Biophys. Res. Commun., 364 (3): 567-72.
[PMID:17963722]
4. Boehm, MF; McClurg, MR; Pathirana, C; Mangelsdorf, D; White, SK; Hebert, J; Winn, D; Goldman, ME; Heyman, RA. (1994) Synthesis of high specific activity [3H]-9-cis-retinoic acid and its application for identifying retinoids with unusual binding properties.
J. Med. Chem., 37 (3): 408-14.
[PMID:8308867]
5. Boehm, MF; Zhang, L; Badea, BA; White, SK; Mais, DE; Berger, E; Suto, CM; Goldman, ME; Heyman, RA. (1994) Synthesis and structure-activity relationships of novel retinoid X receptor-selective retinoids.
J. Med. Chem., 37 (18): 2930-41.
[PMID:8071941]
6. Brown, NS; Smart, A; Sharma, V; Brinkmeier, ML; Greenlee, L; Camper, SA; Jensen, DR; Eckel, RH; Krezel, W; Chambon, P; Haugen, BR. (2000) Thyroid hormone resistance and increased metabolic rate in the RXR-gamma-deficient mouse.
J. Clin. Invest., 106 (1): 73-9.
[PMID:10880050]
7. Canan Koch, SS; Dardashti, LJ; Cesario, RM; Croston, GE; Boehm, MF; Heyman, RA; Nadzan, AM. (1999) Synthesis of retinoid X receptor-specific ligands that are potent inducers of adipogenesis in 3T3-L1 cells.
J. Med. Chem., 42 (4): 742-50.
[PMID:10052980]
8. Cesario, RM; Klausing, K; Razzaghi, H; Crombie, D; Rungta, D; Heyman, RA; Lala, DS. (2001) The rexinoid LG100754 is a novel RXR:PPARgamma agonist and decreases glucose levels in vivo.
Mol. Endocrinol., 15 (8): 1360-9.
[PMID:11463859]
9. Chen, H; Lin, RJ; Schiltz, RL; Chakravarti, D; Nash, A; Nagy, L; Privalsky, ML; Nakatani, Y; Evans, RM. (1997) Nuclear receptor coactivator ACTR is a novel histone acetyltransferase and forms a multimeric activation complex with P/CAF and CBP/p300.
Cell, 90 (3): 569-80.
[PMID:9267036]
10. Chiang, MY; Misner, D; Kempermann, G; Schikorski, T; Giguère, V; Sucov, HM; Gage, FH; Stevens, CF; Evans, RM. (1998) An essential role for retinoid receptors RARbeta and RXRgamma in long-term potentiation and depression.
Neuron, 21 (6): 1353-61.
[PMID:9883728]
11. Dollé, P; Fraulob, V; Kastner, P; Chambon, P. (1994) Developmental expression of murine retinoid X receptor (RXR) genes.
Mech. Dev., 45 (2): 91-104.
[PMID:8199055]
12. Forman, BM. (2002) The antidiabetic agent LG100754 sensitizes cells to low concentrations of peroxisome proliferator-activated receptor gamma ligands.
J. Biol. Chem., 277 (15): 12503-6.
[PMID:11877384]
13. Haugen, BR; Brown, NS; Wood, WM; Gordon, DF; Ridgway, EC. (1997) The thyrotrope-restricted isoform of the retinoid-X receptor-gamma1 mediates 9-cis-retinoic acid suppression of thyrotropin-beta promoter activity.
Mol. Endocrinol., 11 (4): 481-9.
[PMID:9092800]
14. Heyman, RA; Mangelsdorf, DJ; Dyck, JA; Stein, RB; Eichele, G; Evans, RM; Thaller, C. (1992) 9-cis retinoic acid is a high affinity ligand for the retinoid X receptor.
Cell, 68 (2): 397-406.
[PMID:1310260]
15. Hoopes, CW; Taketo, M; Ozato, K; Liu, Q; Howard, TA; Linney, E; Seldin, MF. (1992) Mapping of the mouse Rxr loci encoding nuclear retinoid X receptors RXR alpha, RXR beta, and RXR gamma.
Genomics, 14 (3): 611-7.
[PMID:1358808]
16. Krezel, W; Dupé, V; Mark, M; Dierich, A; Kastner, P; Chambon, P. (1996) RXR gamma null mice are apparently normal and compound RXR alpha +/-/RXR beta -/-/RXR gamma -/- mutant mice are viable.
Proc. Natl. Acad. Sci. U.S.A., 93 (17): 9010-4.
[PMID:8799145]
17. Krezel, W; Ghyselinck, N; Samad, TA; Dupé, V; Kastner, P; Borrelli, E; Chambon, P. (1998) Impaired locomotion and dopamine signaling in retinoid receptor mutant mice.
Science, 279 (5352): 863-7.
[PMID:9452386]
18. Lala, DS; Mukherjee, R; Schulman, IG; Koch, SS; Dardashti, LJ; Nadzan, AM; Croston, GE; Evans, RM; Heyman, RA. (1996) Activation of specific RXR heterodimers by an antagonist of RXR homodimers.
Nature, 383 (6599): 450-3.
[PMID:8837780]
19. Laudet, V. and Gronemeyer, H. (2002) The Nuclear Receptor Facts Book.
in The Nuclear Receptor Facts Book
Academic Press.
20. Leid, M; Kastner, P; Chambon, P. (1992) Multiplicity generates diversity in the retinoic acid signalling pathways.
Trends Biochem. Sci., 17 (10): 427-33.
[PMID:1333659]
21. Leid, M; Kastner, P; Lyons, R; Nakshatri, H; Saunders, M; Zacharewski, T; Chen, JY; Staub, A; Garnier, JM; Mader, S. (1992) Purification, cloning, and RXR identity of the HeLa cell factor with which RAR or TR heterodimerizes to bind target sequences efficiently.
Cell, 68 (2): 377-95.
[PMID:1310259]
22. Levin, AA; Sturzenbecker, LJ; Kazmer, S; Bosakowski, T; Huselton, C; Allenby, G; Speck, J; Kratzeisen, C; Rosenberger, M; Lovey, A. (1992) 9-cis retinoic acid stereoisomer binds and activates the nuclear receptor RXR alpha.
Nature, 355 (6358): 359-61.
[PMID:1309942]
23. Liu, Q; Linney, E. (1993) The mouse retinoid-X receptor-gamma gene: genomic organization and evidence for functional isoforms.
Mol. Endocrinol., 7 (5): 651-8.
[PMID:8391126]
24. Mangelsdorf, DJ; Borgmeyer, U; Heyman, RA; Zhou, JY; Ong, ES; Oro, AE; Kakizuka, A; Evans, RM. (1992) Characterization of three RXR genes that mediate the action of 9-cis retinoic acid.
Genes Dev., 6 (3): 329-44.
[PMID:1312497]
25. Mark, M. and Chambon, P. (2003) Functions of RARs and RXRs in vivo: genetic dissection of the retinoid signaling pathway.
Pure Appl Chem, 75: 1709-1732.
26. Mark, M; Ghyselinck, NB; Chambon, P. (2006) Function of retinoid nuclear receptors: lessons from genetic and pharmacological dissections of the retinoic acid signaling pathway during mouse embryogenesis.
Annu. Rev. Pharmacol. Toxicol., 46: 451-80.
[PMID:16402912]
27. McKenna, NJ; Lanz, RB; O'Malley, BW. (1999) Nuclear receptor coregulators: cellular and molecular biology.
Endocr. Rev., 20 (3): 321-44.
[PMID:10368774]
28. Nagy, L; Thomázy, VA; Shipley, GL; Fésüs, L; Lamph, W; Heyman, RA; Chandraratna, RA; Davies, PJ. (1995) Activation of retinoid X receptors induces apoptosis in HL-60 cell lines.
Mol. Cell. Biol., 15 (7): 3540-51.
[PMID:7791761]
29. Oñate, SA; Tsai, SY; Tsai, MJ; O'Malley, BW. (1995) Sequence and characterization of a coactivator for the steroid hormone receptor superfamily.
Science, 270 (5240): 1354-7.
[PMID:7481822]
30. Thacher, SM; Vasudevan, J; Chandraratna, RA. (2000) Therapeutic applications for ligands of retinoid receptors.
Curr. Pharm. Des., 6 (1): 25-58.
[PMID:10637371]
31. Voegel, JJ; Heine, MJ; Tini, M; Vivat, V; Chambon, P; Gronemeyer, H. (1998) The coactivator TIF2 contains three nuclear receptor-binding motifs and mediates transactivation through CBP binding-dependent and -independent pathways.
EMBO J., 17 (2): 507-19.
[PMID:9430642]
32. Voegel, JJ; Heine, MJ; Zechel, C; Chambon, P; Gronemeyer, H. (1996) TIF2, a 160 kDa transcriptional mediator for the ligand-dependent activation function AF-2 of nuclear receptors.
EMBO J., 15 (14): 3667-75.
[PMID:8670870]
33. Vuligonda, V; Thacher, SM; Chandraratna, RA. (2001) Enantioselective syntheses of potent retinoid X receptor ligands: differential biological activities of individual antipodes.
J. Med. Chem., 44 (14): 2298-303.
[PMID:11428923]